Population PK modeling and exposure-response analyses of sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) in the phase III DECISION trial.
Lars Bastholt
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Marcia S. Brose
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Research Funding - Bayer
Barbara Jarzab
Honoraria - Bayer
Martin Schlumberger
Consultant or Advisory Role - AstraZeneca; Bayer; Eisai; Genzyme
Honoraria - AstraZeneca; Bayer; Eisai; Genzyme
Research Funding - AstraZeneca; Bayer; Eisai; Genzyme
Salvatore Siena
No relevant relationships to disclose
Christelle De La Fouchardiere
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Ralf Paschke
Other Remuneration - Bayer
Hari Anant Deshpande
Consultant or Advisory Role - Bayer
Yuankai Shi
No relevant relationships to disclose
Rossella Elisei
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Ming Gao
No relevant relationships to disclose
Lin Li
No relevant relationships to disclose
Klaas Prins
Consultant or Advisory Role - Bayer
Helen Walker
Consultant or Advisory Role - Bayer
David Y. Mitchell
Consultant or Advisory Role - Bayer
John T. Lettieri
Employment or Leadership Position - Bayer
Istvan Molnar
Employment or Leadership Position - Bayer
Christian Kappeler
Employment or Leadership Position - Bayer
Carol Elaine Pena
Employment or Leadership Position - Bayer